Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Eisai Europe Ltd - Eribulin 10 years on: What is the role of eribulin in the contemporary management of mBC

MBC treatment evolution from the past 10 years

Date

05 May 2021

Session

Eisai Europe Ltd - Eribulin 10 years on: What is the role of eribulin in the contemporary management of mBC

Presenters

Joyce O'Shaughnessy

Authors

J. O'Shaughnessy

Author affiliations

  • Texas Oncology - Baylor Sammons Cancer Center, Dallas/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.